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Streszczenie
W pracy przedstawiono przypadek 60-letniego pacjenta za-
kwalifikowanego do wykonania zabiegu chirurgicznego z roz-
poznaną kardiomiopatią przerostową (hypertrophic cardiomyo­
pathy – HCM), znacznie podwyższonym gradientem w drodze 
odpływu z lewej komory (left ventricular outflow tract – LVOT) 
oraz nieprawidłowym ruchem skurczowym przedniego płatka 
zastawki mitralnej (systolic anterior motion – SAM). W trakcie 
operacji wykonano miektomię przegrodową sposobem Mor-
rowa, lecz pomimo nieustępującego SAM i utrzymujących się 
podwyższonych gradientów w LVOT odstąpiono od wymiany 
zastawki mitralnej. Autorzy prezentują konserwatywne podej-
ście do wymiany zastawki mitralnej podczas operacji HCM.
Słowa kluczowe: nieprawidłowy ruch skurczowy przedniego 
płatka zastawki mitralnej, SAM.
CASE REPORTS
Abstract
The authors report the case of a 60-year-old patient with hyper - 
trophic cardiomyopathy (HCM), systolic anterior motion 
(SAM), and high gradient in the left ventricular outflow tract 
(LVOT) who underwent surgical treatment. During the surgery, 
myomectomy of the septum was performed using the Mor-
row method: despite the persisting SAM and increased LVOT 
gradients, the mitral valve was not replaced. The case study 
presents a conservative approach to mitral valve replacement 
during HCM surgery.
Key words: systolic anterior motion, SAM.
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Introduction
Hypertrophic cardiomyopathy (HCM) is a hereditary dis-
ease of the myocardium; its first descriptions were pub-
lished by Russell Brock in 1957 and Donald Tear in 1958 
[1, 2]. Its definition includes left ventricular hypertrophy 
that is not caused by volume overload (which occurs, e.g., 
in the course of valvular diseases, arterial hypertension, 
and congenital heart defects) [3]. In its most common 
form, the muscle hypertrophy is asymmetric and primar-
ily involves the interventricular septum. Left ventricular 
outflow tract obstruction (LVOTO) at rest is observed in ap-
proximately 25% of patients, but almost 70% of patients 
can be diagnosed with so-called latent LVOTO [4]. Left ven-
tricular outflow tract obstruction is caused by systolic ante-
rior motion (SAM) of the mitral valve and the consequent 
contact between the valve and the interventricular septum 
during systole. As a result, cardiac output decreases sig-
nificantly, and left ventricular filling pressure rises; in time, 
progressive hypertrophy occurs and is followed by myocar-
dial ischemia which manifests as chest pain, dyspnea, and 
syncopes. The first symptom may also come in the form of 
sudden cardiac death [5].
The authors present the case of a 60-year-old patient 
suffering from left ventricular outflow tract obstruction 
with systolic anterior motion and a discussion of the prob-
lems associated with the therapeutic decisions.
Material and methods
The 60-year-old male patient diagnosed with hyper-
trophic cardiomyopathy was admitted to the Department 
of Cardiovascular Surgery and Transplantology, JP II Hos-
pital in Krakow in order to undergo surgical treatment of 
LVOTO. Transthoracic echocardiography (TTE) performed 
before admission revealed massive hypertrophy of the 
basal and middle segments of the interventricular sep-
tum (up to 30 mm) as well as thickening of the remain-
ing cardiac walls. The measured resting gradient in the left 
ventricular outflow tract (LVOT) was 140 mmHg; after the 
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performance of a Valsalva maneuver, it rose to 180 mmHg. 
The patient had been suffering from anginal ailments (CCS 
class II) for the previous two years, and his family medi-
cal history included sudden cardiac death. Transesophageal 
echocardiography confirmed the presence of a very high 
LVOT gradient as well as abnormal motion of the anteri-
or mitral valve cusp (SAM). Additionally, the examination 
demonstrated 1st degree mitral insufficiency (lateral jet). 
The patient was qualified for surgical treatment by the 
heart team.
Results
The procedure was performed using median sternot-
omy, extracorporeal circulation, and general hypothermia 
(28°C). The muscle of the interventricular septum was re-
sected via aortotomy using Morrow’s method: a muscle 
fragment approximately 2 x 1 cm in size and 5 mm in depth 
was excised 1.5 cm below the aortic annulus. Intraoperative 
TEE revealed a drop in the LVOT gradient to 90 mmHg and 
persisting SAM. The aorta was reopened, and an additional 
fragment of the septal muscle was resected (additional 1 cm 
in the direction of the left ventricular apex and additional 
5 mm in depth), resulting in the formation of a “trough” in 
the ventricular septum (3 x 1 cm in size and 1 cm in depth). 
The subsequent intraoperative TEE revealed that the 
gradient decreased further (down to max. 70 mmHg), and, 
despite the persisting SAM, the procedure was ended. In 
the early postoperative period, pressor agents were dis-
continued, and fluid supply was increased. On the second 
postoperative day, transthoracic echocardiography was per-
formed, revealing the maximum gradient through LVOT to 
be 50 mmHg and demonstrating that SAM was still pres-
ent. The patient was discharged from the intensive care unit 
on the 3rd postoperative day. On the postoperative ward, 
treatment with b-blockers and antiarrhythmic agents was 
implemented. After the patient’s heart rate slowed down 
and stabilized, another echographic examination was per-
formed: the maximum gradient through the left ventricular 
outflow tract was 17 mmHg, and the abnormal motion of 
the anterior mitral valve cusp (SAM) was no longer present. 
The patient was discharged from the clinic on the 8th post-
operative day in good general condition, without complaints.
Discussion
The mechanism of the systolic motion of the anterior 
mitral valve cusp (SAM) in HCM patients results from an-
terior displacement of the mitral valve’s papillary mus-
cles and the Venturi effect caused by intense blood flow 
through the narrow outlet of the left cardiac ventricle. Both 
these mechanisms result in the development of forces pull-
ing on the mitral valve cusp in the direction of the inter-
ventricular septum [6, 7]. Additionally, anomalous papillary 
muscle insertion directly into the anterior mitral valve cusp 
can be observed in some patients [8]. The abnormal motion 
of the anterior mitral valve cusp is accompanied by mitral 
insufficiency, which is visualized by echocardiographic ex-
amination as a jet that is directed posteriorly or laterally 
[9]. Mitral insufficiency in HCM can also be caused by ab-
normalities in the internal structure of the mitral valve, as 
can be inferred from insufficiency jets directed centrally or 
anteriorly.
Approximately 5-30% of HCM patients require surgical 
treatment of LVOTO and SAM [10]. For over 40 years, the 
gold standard of surgical management has been septal my-
ectomy using the Morrow method; it consists in the exci-
sion of a fragment of the interventricular septum from ap-
proximately 2 cm below the aortic annulus in the direction 
of the left ventricular apex (approximately 3-4 cm in length 
and approximately 1 cm in width), thus widening the out-
flow tract and stopping the forces causing SAM [11]. Some 
authors suggest performing a more extensive resection of 
the septal muscle (7-8 cm) [12, 13] and partially freeing the 
insertion of the papillary muscles from the left ventricular 
wall [13]. In the case of concomitant significant mitral insuf-
ficiency associated with anomalous valve structure, it be-
comes necessary to repair or replace the valve. The efficacy 
of septal myectomy is assessed intraoperatively using trans-
esophageal echocardiography (TEE) in order to confirm the 
reduction of LVOT gradients and the lack of SAM. There are 
no unequivocal management guidelines for cases in which 
intraoperative examination reveals the persistence of SAM; 
the guidelines also do not specify when the decision to re-
place the mitral valve should be taken. In the vast majority 
of cases, the decision to replace the mitral valve is made 
intraoperatively by the surgeon, based on their experience 
and considering the valve anatomy. According to the litera-
ture, in most cases in which three attempts to stop SAM 
had failed, as confirmed by intraoperative echo, a decision 
was made to replace the mitral valve.
In the present case, a more conservative approach was 
employed. Despite the performance of two septal muscle 
resections and the persistence of abnormal mitral leaflet 
motion demonstrated by intraoperative evaluation, a deci-
sion was made not to replace the mitral valve, which was 
based primarily on the amount of LVOT gradient reduction. 
As can be surmised from this case, intraoperative echocar-
diography does not always reflect the actual (target) post-
operative gradients, which can be properly assessed only 
after fluid replacement and implementation of appropriate 
pharmacological treatment of the underlying condition, i.e., 
hypertrophic cardiomyopathy. In cases in which SAM per-
sists, mitral valve replacement can always be performed at 
a later time as the ultimate solution.
Conclusions
A conservative approach should always be considered 
in cases in which myomectomy must be performed in SAM 
patients.
The target postoperative gradients can be properly as-
sessed only after fluid replacement and implementation of 
appropriate pharmacological treatment.
It appears that therapeutic decisions should be based 
on the amount of gradient reduction during the Morrow 
procedure, rather than on absolute gradient values.
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